Germ line polymorphisms of p53 and cyp1a1 genes involved in human lung cancer

Carcinogenesis

Volumn 14, Issue 6, 1993, Pages 1085-1089

  Kawajiri, Kaname ^a   Nakachi, Kei ^a   Imai, Kazue ^a   Watanabe, Junko ^a   Hayashi, Shin Ichi ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; GLUTATHIONE TRANSFERASE; NUCLEAR PROTEIN; PROTEIN P53;

ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SMOKING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CODON; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMAN; LUNG NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RISK; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0027266826     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/14.6.1085     Document Type: Article

References (29)

1. Omenn, G.S. and Gelboin, H.V. (eds) (1984) Genetic Variability in Responses to Chemical Exposure, Banbury Report 16. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 3-395.
2. International Agency for Research on Cancer (1986) ARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. IARC, Lyon, Vol. 38, pp. 83-126.
3. Amos, C.I., Caporaso, N.E. and Weston, A. (1992) Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev., 1, 505-513.
4. Idle, J.R. (1991) Is environmental carcinogenesis modulated by host polymorphism? Mutât. Res., 247, 259-266.
5. Nebert, D.W. (1991) Role of genetics and drug metabolism in human cancer risk. Mutât.Res., 247, 267-281.
6. Omenn, G.S. (1991) Future research directions in cancer ecogenetics. Mutât.Res., 247, 283-291.
7. Caporaso, N., Landi, M.T. and Vineis, P. (1991) Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics, 1, 4-19.
8. Hayashi, S.-L, Watanabe, I., Nakachi, K. and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated Msp 1 polymorphisms with amino acid replacement in the heme-binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407-411.
9. Hayashi, S.I., Watanabe, J. and Kawajiri, K. (1992) High susceptibility to lung cancer analyzed in terms of combinai genotypes of P450IA1 and Mu-class glutathione S-transferase. Jpn. J. Cancer Res., 83, 866-870.
10. Takahashi, T., Nau, M.M., Chiba, L., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Passai, F., Gazdar, A.F. and Minna, J.D. (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
11. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
12. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetler, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C. and Vogelstein, B. (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature, 342, 705-708.
13. Suzuki, I., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., Takahashi, T. and Ueda, R. (1992) p53 Mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52, 734-736.
14. Puisieux, A., Lim, S., Groopman, J. and Ozturk, M. (1991) Selective targeting of p53 gene mutational hotspots in human cancers by etkrfogicalLy defined carcinogens. Cancer Res., 51, 6185-6189.
15. Strauss, B.S. (1992) The origin of point mutatiMB in human tumor cdls. Cancer Res., 52, 249-253.
16. Fields, S. and Jang, S.K. (1990) Presence of a potent transcription activating sequence in the p53 protein. Science, 249, 1046-1049.
17. Raycroft, L., Wu, H. and Lozano, G. (1990) Transcriptional activation by wildtype but not transforming mutants of the p53 anti-oncogene. Science, 249, 1049-1051.
18. Bargonetti, J., Friedman, P.N., Kem, S.E. and Prives, C. (1991) Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell, 65, 1083-1091.
19. Kem, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. (1991) Identification of p53 as a sequence-specific DNA- binding protein. Science, 252, 1708-1711.
20. Ullrich, S.J., Anderson, C.W., Mercer, W.E. and Appella, E. (1992) The p53 tumor suppressor protein, a modulator of cell proliferation. J. BioL Chem., 267, 15259-15262.
21. Seto, E., Usheva, D., Zambetti, G.P., Monand, J., Horikoshi, N., Weinmann, R., Levine, A.J. and Shenk, T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA, 89, 12028-12032.
22. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., Kassel J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A. and Friend, S.H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
23. Matlashewski, G.J., Tuck, S., Pim, D., Lamb, P., Schneider, J. and Crawford, L.V. (1987) Primaty structure polymorphism at amino acid residue 72 of human p53. Mol Cell. Biol., 7, 961-963.
24. Buchman, V.L., Chumakov, P.M., Ninkina, N.N., Samarina, O.P. and Georgiev, G.P. (1988) A variation in the structure of the protein-coding region of the human p53 gene. Gene, 70, 245-252.
25. dela Calle-Maitin, O., Fabregat, V., Romero, M., Soler, J., Vives, J. and Yague, J. (1990) Acc II polymorphism of the p53 gene. Nucleic Acids Res., 18, 463.
26. Ara, S., Lee, P.S.Y., Hansen, M.F. and Saya, H. (1990) Codon 72 polymorphism of the TP53 gene. Nucleic Adds Res., 18, 4961.
27. Weston, A., Perrin, L.S., Forrester, K., Hoover, R.N., Trump, B.F., Harris, C.C. and Caporaso, N.E. (1992) Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev., 1, 481-483.
28. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J. and Hayashi, S.I. (1993) The CYP1A1 gene and cancer susceptibility. Off. Rev. Oncol HematoL, in press.
29. Nakachi, K., Imai, K., Hayashi, S.I., Watanabe, J. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.